718
Participants
Start Date
March 26, 2018
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
No intervention
According to clinical practice.
Righospitalet Copenhagen, Copenhagen
Centre Hospitalier Intercommunal de Creteil, Créteil
Centre d'Investigation Clinique Centre National d'Ophtalmologie des Quinze-Vingts, Paris
University Hospital Bonn, Bonn
University Hospital Cologne, Cologne
Department of Ophthalmology, University of Freiburg, Freiburg im Breisgau
University Eye Hospital Munich, Munich
St. Franziskus Hospital, Münster
Universtiy Hospital Tuebingen, Tübingen
University Eye Hospital Ulm, Ulm
Luigi Sacco Hospital, Milan
Ospedale San Raffaele, Milan
G.B.Bietti Eye Foundation, Rome
Radboud University Medical Centre, Leiden
Radboud University Medical Centre, Nijmegen
Centre for Clinical Trials, AIBILI, Coimbra
Centro Hospitalar de São João, E.P.E., Porto
Queen's University Belfast, Belfast
Gloucestershire Hospitals NHS Foundation Trust, Gloucester
Moorfields Eye Hospital, London
Collaborators (3)
Bayer
INDUSTRY
Moorfields Eye Hospital NHS Foundation Trust
OTHER
Novartis Pharmaceuticals
INDUSTRY
Association for Innovation and Biomedical Research on Light and Image
OTHER
City, University of London
OTHER
European Clinical Research Infrastructure Network
OTHER
La Fondation Voir et Entendre
UNKNOWN
Hoffmann-La Roche
INDUSTRY
Radboud University Medical Center
OTHER
University of Sheffield
OTHER
University College, London
OTHER
Carl Zeiss Meditec AG
INDUSTRY
Innovative Medicines Initiative
OTHER
Frank G. Holz
OTHER